Hematology

Special Issues

Following special issues within this section are currently open for submissions:

• New Developments in the Field of Myeloid Neoplasms (Deadline: 31 January 2021)
• Diagnosis and Management of Thrombocytopenia (Deadline: 31 January 2021)
• The Latest Clinical Advances in Thrombocytopenia (Deadline: 31 January 2021)
• Diagnostics and Management of Myelodysplastic Syndromes (Deadline: 31 January 2021)
• Diagnosis and Management of Autoimmune Hemolytic Anemias (Deadline: 28 February 2021)
• The Clinical Epidemiology of Sickle Cell Disease, a Severe Multi-Organ Affection (Deadline: 28 February 2021)
• Lymphoma：New Diagnosis and Current Treatment Strategies (Deadline: 1 March 2021)
• Progresses in Hematopoietic Stem Cell Tranplantation and Cellular Therapies (Deadline: 30 March 2021)
• Advance in the Treatment of Pediatric Leukemia (Deadline: 31 March 2021)
• Myelodysplastic Syndromes: From Inflammatory to Therapeutic Approaches (Deadline: 31 March 2021)
• Stem Cell Transplantation in Hematological Malignancies (Deadline: 31 March 2021)
• Diagnosis and Treatment of Hemophilia (Deadline: 31 March 2021)
• Current Challenges and Advances in Pediatric Thrombosis (Deadline: 30 April 2021)
• Neonatal Hematology and Blood Transfusions (Deadline: 30 April 2021)
• Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives (Deadline: 30 April 2021)
• Myeloid-Derived Suppressor Cells (MDSCs) in Haematology (Deadline: 30 April 2021)
• Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management (Deadline: 1 June 2021)
• Diagnosis and Management of Blood Diseases (Deadline: 30 June 2021)
• Chronic Myeloid Leukemia: Diagnosis and Treatment (Deadline: 30 June 2021)
• Precision Medicine in Beta-Thalassemia and Sickle-Cell Disease: Markers, Diagnosis and Therapy (Deadline: 30 June 2021)
• The Role of the Microenvironment in Multiple Myeloma: From Biology to Clinical Practice (Deadline: 31 July 2021)
• Haemophilia: Current Treatment and Challenge (Deadline: 31 July 2021)
• Advances in the Management of Aggressive Lymphomas (Deadline: 31 July 2021)
• Prognosis and Therapy of Chronic Myeloid Leukemia (Deadline: 31 July 2021)
• Optimizing Treatment Outcomes in Sickle Cell Disease (Deadline: 31 July 2021)
• Diagnosis, Treatment, Management and Prognosis of Acute Leukemia (AML and ALL): Current Challenges and Opportunities (Deadline: 30 September 2021)
• Unusual Clinical Presentation of Covid-19 (Deadline: 30 November 2021)
• Hematopoietic Stem Cell Transplantation: Current Status and Future Research (Deadline: 15 December 2021)